These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19043279)

  • 1. Effect of pharmacokinetic profile on the pancreatic toxicity and efficacy of tacrolimus in rats.
    Mitamura T; Yamada A; Hanaoka K; Asano M; Niwa T; Seki J
    J Toxicol Sci; 2008 Dec; 33(5):575-84. PubMed ID: 19043279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.
    Song GW; Lee SG; Hwang S; Kim KH; Kim WJ; Sin MH; Yoon YI; Tak EY
    Exp Clin Transplant; 2016 Aug; 14(4):412-8. PubMed ID: 26976646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cataract development induced by repeated oral dosing with FK506 (tacrolimus) in adult rats.
    Ishida H; Mitamura T; Takahashi Y; Hisatomi A; Fukuhara Y; Murato K; Ohara K
    Toxicology; 1997 Dec; 123(3):167-75. PubMed ID: 9355935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients.
    Wallemacq PE; Furlan V; Möller A; Schäfer A; Stadler P; Firdaous I; Taburet AM; Reding R; Clement De Clety S; De Ville De Goyet J; Sokal E; Lykavieris L; Van Leeuw V; Bernard O; Otte JB; Undre NA
    Eur J Drug Metab Pharmacokinet; 1998; 23(3):367-70. PubMed ID: 9842978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged Administration of Twice-Daily Bolus Intravenous Tacrolimus in the Early Phase After Lung Transplantation.
    Hirano Y; Sugimoto S; Mano T; Kurosaki T; Miyoshi K; Otani S; Yamane M; Kobayashi M; Miyoshi S; Oto T
    Ann Transplant; 2017 Aug; 22():484-492. PubMed ID: 28798289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative bioavailability of single doses of prolonged-release tacrolimus administered as a suspension, orally or via a nasogastric tube, compared with intact capsules: a phase 1 study in healthy participants.
    Undre N; Dickinson J
    BMJ Open; 2017 Apr; 7(4):e012252. PubMed ID: 28377389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic toxicity of tacrolimus given by various routes and the response to dose reduction.
    Akar Y; Yucel G; Durukan A; Yucel I; Arici G
    Clin Exp Ophthalmol; 2005 Feb; 33(1):53-9. PubMed ID: 15670079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebulized cyclosporine for prevention of acute pulmonary allograft rejection in the rat: pharmacokinetic and histologic study.
    Blot F; Tavakoli R; Sellam S; Epardeau B; Faurisson F; Bernard N; Becquemin MH; Frachon I; Stern M; Pocidalo JJ
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1162-72. PubMed ID: 8719464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.
    Nashan B; Saliba F; Durand F; Barcéna R; Herrero JI; Mentha G; Neuhaus P; Bowles M; Patch D; Bernardos A; Klempnauer J; Bouw R; Ives J; Mamelok R; McKay D; Truman M; Marotta P
    Liver Transpl; 2009 Feb; 15(2):136-47. PubMed ID: 19177449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus and sirolimus cause insulin resistance in normal sprague dawley rats.
    Larsen JL; Bennett RG; Burkman T; Ramirez AL; Yamamoto S; Gulizia J; Radio S; Hamel FG
    Transplantation; 2006 Aug; 82(4):466-70. PubMed ID: 16926589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced variability in tacrolimus pharmacokinetics following intramuscular injection compared to oral administration in cynomolgus monkeys: Investigating optimal dosing regimens.
    Lee KW; Kim TH; Lee JB; Kim KS; Park JB; Gershkovich P; Yoo SD; Shin S; Shin BS; Kim SJ
    J Pharmacol Sci; 2019 Feb; 139(2):65-71. PubMed ID: 30573325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong additive effect of 1,25-dihydroxycholecalciferol and cyclosporine A but not tacrolimus in rat lung allotransplantation.
    Stammberger U; Kubisa B; Gugger M; Ayuni E; Claudio R; Grodzki T; Schmid RA
    Eur J Cardiothorac Surg; 2003 Aug; 24(2):196-200; discussion 200. PubMed ID: 12895607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of prolonged-release tacrolimus and implications for use in solid organ transplant recipients.
    Tanzi MG; Undre N; Keirns J; Fitzsimmons WE; Brown M; First MR
    Clin Transplant; 2016 Aug; 30(8):901-11. PubMed ID: 27220013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronopharmacology of tacrolimus in rats: toxicity and efficacy in a mouse-to-rat intestinal transplant model and its pharmacokinetic profile.
    Uchida H; Kobayashi E; Ogino Y; Mizuta K; To H; Okabe R; Hashizume K; Fujimura A
    Transplant Proc; 1999 Nov; 31(7):2751-3. PubMed ID: 10578276
    [No Abstract]   [Full Text] [Related]  

  • 16. Chrono and clinical pharmacokinetic study of tacrolimus in continuous intravenous administration.
    Satoh S; Tada H; Tachiki Y; Tsuchiya N; Shimoda N; Akao T; Sato K; Habuchi T; Suzuki T; Kato T
    Int J Urol; 2001 Jul; 8(7):353-8. PubMed ID: 11442656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic Study of Conversion Between 2 Formulations of Once-daily Extended-release Tacrolimus in Stable Lung Transplant Patients.
    Sintes H; Sáez-Giménez B; Berastegui C; López-Meseguer M; Monforte V; Bravo C; Vima J; Gómez-Ollés S; Roman A
    Transplantation; 2018 Oct; 102(10):e439-e446. PubMed ID: 29965950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effect of candesartan cilexetil on the steady-state pharmacokinetics of tacrolimus in renal transplant patients.
    Pietruck F; Kiel G; Birkel M; Stahlheber-Dilg B; Philipp T
    Biopharm Drug Dispos; 2005 May; 26(4):135-41. PubMed ID: 15768377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic changes of intravenous tacrolimus in rats with uranyl nitrate-induced acute renal failure.
    Son IJ; Moon YJ; Lee MG; Sohn YT
    Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):359-68. PubMed ID: 11958289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
    Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
    Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.